The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Expert Opin Pharmacother
; 8(11): 1769-77, 2007 Aug.
Article
en En
| MEDLINE
| ID: mdl-17685892
Many factors influence the effectiveness of contraceptive methods. Oral contraceptives are the second most popular contraceptive method after female sterilization in the US. A total of 25% of women do not use their oral contraceptives correctly; 30% of women do not use them consistently. Several new contraceptive methods with alternate routes of delivery and less frequent dosing are available. The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring is marketed under the name of NuvaRing. This is the only contraceptive ring approved by the FDA. The administration of steroids by the vaginal route may offer many advantages. Because of less frequent dosing, self-administration, and possibly, an improved side effect profile, the ring has the potential to increase successful use.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Desogestrel
/
Dispositivos Anticonceptivos Femeninos
/
Etinilestradiol
Límite:
Animals
/
Female
/
Humans
Idioma:
En
Revista:
Expert Opin Pharmacother
Asunto de la revista:
FARMACOLOGIA
Año:
2007
Tipo del documento:
Article
País de afiliación:
Canadá
Pais de publicación:
Reino Unido